IRIS Accounts Production v24.2.0.383 05041806 Board of Directors 1.3.23 29.2.24 29.2.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh050418062023-02-28050418062024-02-29050418062023-03-012024-02-29050418062022-02-28050418062022-03-012023-02-28050418062023-02-2805041806ns15:EnglandWales2023-03-012024-02-2905041806ns14:PoundSterling2023-03-012024-02-2905041806ns10:Director12023-03-012024-02-2905041806ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2905041806ns10:SmallEntities2023-03-012024-02-2905041806ns10:AuditExempt-NoAccountantsReport2023-03-012024-02-2905041806ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-2905041806ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-2905041806ns10:AbridgedAccounts2023-03-012024-02-2905041806ns10:Director22023-03-012024-02-2905041806ns10:CompanySecretary12023-03-012024-02-2905041806ns10:RegisteredOffice2023-03-012024-02-2905041806ns5:CurrentFinancialInstruments2024-02-2905041806ns5:CurrentFinancialInstruments2023-02-2805041806ns5:ShareCapital2024-02-2905041806ns5:ShareCapital2023-02-2805041806ns5:RetainedEarningsAccumulatedLosses2024-02-2905041806ns5:RetainedEarningsAccumulatedLosses2023-02-28
REGISTERED NUMBER: 05041806 (England and Wales)















K BRENNAN MEDICAL SERVICES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

29 FEBRUARY 2024






K BRENNAN MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05041806)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


K BRENNAN MEDICAL SERVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 29 FEBRUARY 2024







DIRECTORS: Dr K Brennan
Mrs A C Brennan





SECRETARY: Mrs A C Brennan





REGISTERED OFFICE: Sidings House
Sidings Court
Lakeside
Doncaster
South Yorkshire
DN4 5NU





REGISTERED NUMBER: 05041806 (England and Wales)






K BRENNAN MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05041806)

ABRIDGED BALANCE SHEET
29 FEBRUARY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Investments 4 121,892 96,700

CURRENT ASSETS
Debtors 394 19,255
Cash at bank 31,498 16,154
31,892 35,409
CREDITORS
Amounts falling due within one year 4,674 8,878
NET CURRENT ASSETS 27,218 26,531
TOTAL ASSETS LESS CURRENT
LIABILITIES

149,110

123,231

PROVISIONS FOR LIABILITIES 6,021 -
NET ASSETS 143,089 123,231

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 142,989 123,131
SHAREHOLDERS' FUNDS 143,089 123,231

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

K BRENNAN MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05041806)

ABRIDGED BALANCE SHEET - continued
29 FEBRUARY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 29 February 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 November 2024 and were signed on its behalf by:





Dr K Brennan - Director


K BRENNAN MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05041806)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024


1. STATUTORY INFORMATION

K Brennan Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST OR VALUATION
At 1 March 2023 96,700
Additions 1,107
Revaluations 24,085
At 29 February 2024 121,892
NET BOOK VALUE
At 29 February 2024 121,892
At 28 February 2023 96,700

Cost or valuation at 29 February 2024 is represented by:
Totals
£   
Valuation in 2024 24,085
Cost 97,807
121,892

K BRENNAN MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05041806)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 29 FEBRUARY 2024


5. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At 29 February 2024, the company owed its directors £143 (2023 £52). The loan is interest free and has no formal repayment terms.

6. ULTIMATE CONTROLLING PARTY

The company is controlled by the directors who hold the entire share capital.